Related Experiment Video
Updated: Jul 7, 2026

HOX Loci Focused CRISPR/sgRNA Library Screening Identifying Critical CTCF Boundaries
Published on: March 31, 2019
FOXO-regulated transcription restricts overgrowth of Tsc mutant organs
Kieran F Harvey1, Jaakko Mattila, Avi Sofer
1Cell Growth and Proliferation Laboratory, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. kieran.harvey@petermac.org
Abstract:
FOXO is thought to function as a repressor of growth that is, in turn, inhibited by insulin signaling. However, inactivating mutations in Drosophila melanogaster FOXO result in viable flies of normal size, which raises a question over the involvement of FOXO in growth regulation. Previously, a growth-suppressive role for FOXO under conditions of increased target of rapamycin (TOR) pathway activity was described. Here, we further characterize this phenomenon. We show that tuberous sclerosis complex 1 mutations cause increased FOXO levels, resulting in elevated expression of FOXO-regulated genes, some of which are known to antagonize growth-promoting pathways. Analogous transcriptional changes are observed in mammalian cells, which implies that FOXO attenuates TOR-driven growth in diverse species.
Insights
Forkhead box O (FOXO) transcription factors suppress growth, particularly when the target of rapamycin (TOR) pathway is active. This study shows FOXO antagonizes TOR-driven growth across species, including mammals.
Area of Science:
- Molecular Biology
- Genetics
- Cellular Biology
Background:
- The role of FOXO (Forkhead box O) transcription factors in growth regulation is debated, as FOXO mutations in Drosophila do not affect fly size.
- A previous study indicated FOXO suppresses growth under conditions of heightened target of rapamycin (TOR) pathway activity.
Purpose of the Study:
- To further investigate the growth-suppressive role of FOXO, particularly in relation to the TOR pathway.
- To determine if FOXO antagonizes TOR-driven growth in a conserved manner across species.
Main Methods:
- Utilizing Drosophila melanogaster models with mutations in tuberous sclerosis complex 1 (TSC1).
- Analyzing FOXO levels and the expression of FOXO-regulated genes in response to TSC1 mutations.
- Comparing transcriptional changes in Drosophila with those in mammalian cell lines.
Main Results:
- Mutations in TSC1 led to increased FOXO levels in Drosophila.
- Elevated FOXO levels resulted in increased expression of genes that counteract growth-promoting pathways.
- Similar transcriptional alterations were observed in mammalian cells, indicating conserved mechanisms.
Conclusions:
- FOXO acts as a suppressor of growth, specifically counteracting growth promoted by the TOR pathway.
- This growth-attenuating function of FOXO is conserved in both insects and mammals, highlighting its fundamental role in metabolic and growth control.
More Related Videos
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
General Transcription Factors
Master Transcription Regulators
Pleiotropy
Transgenic Organisms

